1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Summary of vessel diameter and blood flow measures stratified by disease stagea
Control (Mean) (SD) (n = 20 OA, 24 ICA) Early AMD (Mean) (SD) (n = 9 OA, 15 ICA) Interm. AMD(Mean) (SD) (n = 7 OA, 8 ICA) Late AMD (Mean) (SD) (n = 12 OA, 17 ICA) All AMD (Mean) (SD) (n = 28 OA, 40 ICA) OA diameter (mm) 1.1 (0.19) 0.9 (0.25)P = .11 1.0 (0.26)P = .42 0.8 (0.25)P < .01b 0.9 (0.26)P < .01b OA volume flow (mL/min) 7.0 (3.0) 6.5 (4.2)P = .74 5.6 (3.1)P = .37 3.8 (1.8)P < .01b 5.1 (3.2)P = .07 OA flow velocity (cm/s)c 13.1 (4.0) 16.0 (4.5)P < .01b 11.9 (4.3)P = .91 15.0 (5.7)P = .03b 14.6 (5.1)P = .02b OA RI 0.70 (0.10) 0.82 (0.10)P < .01b 0.81 (0.06)P < .01b 0.80 (0.07)P < .01b 0.81 (0.08)P < .01b ICA diameter (mm) 4.3 (0.51) 4.2 (0.52)P = .38 4.6 (0.63)P = .47 4.2 (0.44)P = .55 4.3 (0.52)P = .67 ICA volume flow (mL/min)c 163.1 (44.8) 154.3 (44.2)P = .98 167.0 (23.4)P = .49 166.6 (27.7)P = .19 162.2 (33.8)P = .46 ICA flow velocity (cm/s)c 18.3 (3.5) 18.7 (3.7)P = .07 17.8 (4.5)P = .58 20.6 (5.2)P < .01b 19.4 (4.6)P < .01b ICA RI 0.61 (0.09) 0.66 (0.09)P = .18 0.70 (0.04)P < .01b 0.65 (0.11)P = .29 0.67 (0.09)P = .07
Note:—RI indicates resistance index; Interm., intermediate.
a Values represent group mean and group SD, and reported P values indicate significance relative to controls based on a GEE analysis followed by post hoc least significant difference comparisons between disease groups and controls. The sample size for ophthalmic artery measurements was 48 hemisphere measurements from 30 subjects. The sample size for the ICA measurements was 64 hemispheres of 33 subjects.
↵b Tests that were significant at the P < .05 level (uncorrected).
↵c Adjusted for age, which was statistically significant (P < .05) in the GEE model.